Drug intelligence / Profile preview

Alofec

Development stage
Unknown
Lead developer
Fundación IMABIS
Modality
Stem Cell Therapies → Cell Therapies
Administration
Local Injection
01

Overview

Alofec is an investigational allogeneic cell therapy composed of adipose-derived mesenchymal stem cells (ASCs). Developed by the Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS), it is specifically designed for the treatment of faecal incontinence. The therapy involves the local, intrasphincteric injection of these stem cells, which are hypothesized to promote the regeneration of the anal sphincter muscle and modulate local inflammatory responses through paracrine signaling. This regenerative approach aims to restore sphincter function and improve quality of life for patients who have not responded to conventional treatments. Alofec has been evaluated in Phase II clinical trials in Spain.

Brand names
Alofec
Other names
Allogeneic adipose-derived mesenchymal stem cellsAllogeneic adipose-derived mesenchymal stromal cells

Beyond the preview

Go deeper on Alofec.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alofec.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call